Hanne Madsen

Medicin og biovidenskab

1. Asthma 100%
2. Adrenal Cortex Hormones 63%
3. Omalizumab 42%
4. Chronic Obstructive Pulmonary Disease 35%
5. mepolizumab 32%
6. Phenprocoumon 30%
7. Denmark 26%
8. Mephenytoin 25%
9. Tramadol 25%
10. Mortality 24%
11. Imipramine 23%
12. Vitamin K 22%
13. Cohort Studies 20%
14. Young Adult 20%
15. Sparteine 19%
16. reslizumab 18%
17. Bronchial Thermoplasty 17%
18. dupilumab 16%
19. Demethylation 16%
20. Breathing Exercises 16%
21. Cytochrome P-450 CYP1A2 15%
22. Meta-Analysis 14%
23. Randomized Controlled Trials 14%
24. Systematic Reviews 14%
25. Drug Substitution 14%
26. Leukocyte L1 Antigen Complex 13%
27. Drug Utilization 13%
28. Cytochrome P-450 CYP2C19 13%
29. Prospective Studies 12%
30. Desipramine 12%
31. Quality of Life 12%
32. Neurofibromatosis 1 12%
33. Colorectal Surgery 12%
34. Pharmaceutical Preparations 11%
35. Morbidity 11%
36. Cytochrome P-450 CYP3A 11%
37. Interleukin-5 10%
38. Pneumothorax 10%
39. Warfarin 10%
40. Lung 10%
41. Complementary Therapies 10%
42. Osteoporosis 9%
43. Proguanil 9%
44. Guidelines 9%
45. Vitamin D 9%
46. Drug-Related Side Effects and Adverse Reactions 9%
47. Population 9%
48. Anti-Bacterial Agents 8%
49. Patient Selection 8%
50. Respiration 8%